Evidence map›Paper›PMID 25476971›Full record

ReviewNeuropharmacology2015

The habenulo-interpeduncular pathway in nicotine aversion and withdrawal.

Beatriz Antolin-Fontes, Jessica L Ables, Andreas Görlich, Inés Ibañez-Tallon

Registry-linked trialAbstract readReview
In one paragraph

Review in Neuropharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03463590 (Deep Brain Stimulation of the Bilateral Habenula for Treatment-Refractory Obsessive-Compulsive Disorder), which is not on this map. Cited by 87 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03463590 naunknown statusnot on this mapstarted 2018, after this paper: background citation

Deep Brain Stimulation of the Bilateral Habenula for Treatment-Refractory Obsessive-Compulsive Disorder

TypeinterventionalSponsorRuijin HospitalRan2018 to 2020Enrolled6ConditionsObsessive-Compulsive DisorderArmsBilateral surgical implantation of DBS system to habenula
3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Asymmetrical modulation of fear expression via GABAProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. GABAIBRO neuroscience reports · 2025
    Article
  13. Review
  14. Novel neurotherapeutic targets for substance use disorders: Neuroplasticity, neuroinflammation, gasotransmitters and non-canonical organ systems.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. A rare variant inProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Beatriz Antolin-FontesLaboratory of Molecular Biology and Howard Hughes Medical Institute, The Rockefeller University, 1230 York Avenue, NY 10065, New York, USA.
Jessica L AblesLaboratory of Molecular Biology and Howard Hughes Medical Institute, The Rockefeller University, 1230 York Avenue, NY 10065, New York, USA.
Andreas GörlichLaboratory of Molecular Biology and Howard Hughes Medical Institute, The Rockefeller University, 1230 York Avenue, NY 10065, New York, USA.
Inés Ibañez-TallonLaboratory of Molecular Biology and Howard Hughes Medical Institute, The Rockefeller University, 1230 York Avenue, NY 10065, New York, USA. Electronic address: iibanez@rockefeller.edu.

Funding

RESEARCH SUPPORT CORE 4P30DA035756 · NIDA · ROCKEFELLER UNIVERSITY · PI HEINTZ, NATHANIEL · 2013 to 2017
$6.7M
NIDA NIH HHS 1P30 DA035756-01NIDA NIH HHS P30 DA035756
6 · The paper itself

Abstract

Progress has been made over the last decade in our understanding of the brain areas and circuits involved in nicotine reward and withdrawal, leading to models of addiction that assign different addictive behaviors to distinct, yet overlapping, neural circuits (Koob and Volkow, 2010; Lobo and Nestler, 2011; Tuesta et al., 2011; Volkow et al., 2011). Recently the habenulo-interpeduncular (Hb-IPN) midbrain pathway has re-emerged as a new critical crossroad that influences the brain response to nicotine. This brain area is particularly enriched in nicotinic acetylcholine receptor (nAChR) subunits α5, α3 and β4 encoded by the CHRNA5-A3-B4 gene cluster, which has been associated with vulnerability to tobacco dependence in human genetics studies. This finding, together with studies in mice involving deletion and replacement of nAChR subunits, and investigations of the circuitry, cell types and electrophysiological properties, have begun to identify the molecular mechanisms that take place in the MHb-IPN which underlie critical aspects of nicotine dependence. In the current review we describe the anatomical and functional connections of the MHb-IPN system, as well as the contribution of specific nAChRs subtypes in nicotine-mediated behaviors. Finally, we discuss the specific electrophysiological properties of MHb-IPN neuronal populations and how nicotine exposure alters their cellular physiology, highlighting the unique role of the MHb-IPN in the context of nicotine aversion and withdrawal. This article is part of the Special Issue entitled 'The Nicotinic Acetylcholine Receptor: From Molecular Biology to Cognition'.

Indexed as

AnimalsHabenulaHumansInterpeduncular NucleusMiceNeural PathwaysNeuronsNicotineNicotinic AgonistsReceptors, NicotinicSubstance Withdrawal SyndromeTobacco Use DisorderNicotineNicotinic AgonistsReceptors, NicotinicHabenulaInterpeduncular nucleusnAChRNicotinePacemaking

Identifiers

PMID25476971
PMCPMC4452453

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.